IT202000000616A1 - Impiego di glutaraldeide deprivata di acidi per la preparazione di tessuti biologici per bio-protesi e prevenzione della loro calcificazione - Google Patents
Impiego di glutaraldeide deprivata di acidi per la preparazione di tessuti biologici per bio-protesi e prevenzione della loro calcificazioneInfo
- Publication number
- IT202000000616A1 IT202000000616A1 IT102020000000616A IT202000000616A IT202000000616A1 IT 202000000616 A1 IT202000000616 A1 IT 202000000616A1 IT 102020000000616 A IT102020000000616 A IT 102020000000616A IT 202000000616 A IT202000000616 A IT 202000000616A IT 202000000616 A1 IT202000000616 A1 IT 202000000616A1
- Authority
- IT
- Italy
- Prior art keywords
- calcification
- glutaraldehyde
- prosthesis
- bio
- preventing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102020000000616A IT202000000616A1 (it) | 2020-01-15 | 2020-01-15 | Impiego di glutaraldeide deprivata di acidi per la preparazione di tessuti biologici per bio-protesi e prevenzione della loro calcificazione |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102020000000616A IT202000000616A1 (it) | 2020-01-15 | 2020-01-15 | Impiego di glutaraldeide deprivata di acidi per la preparazione di tessuti biologici per bio-protesi e prevenzione della loro calcificazione |
Publications (1)
Publication Number | Publication Date |
---|---|
IT202000000616A1 true IT202000000616A1 (it) | 2021-07-15 |
Family
ID=70295755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT102020000000616A IT202000000616A1 (it) | 2020-01-15 | 2020-01-15 | Impiego di glutaraldeide deprivata di acidi per la preparazione di tessuti biologici per bio-protesi e prevenzione della loro calcificazione |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT202000000616A1 (it) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030125813A1 (en) | 2002-01-03 | 2003-07-03 | Carpentier Sophie M. | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
US20060217804A1 (en) * | 2005-03-25 | 2006-09-28 | Dove Jeffrey S | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
EP1861132A2 (en) | 2005-03-25 | 2007-12-05 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
US8426199B2 (en) | 2007-02-24 | 2013-04-23 | Gfe Nanomedical International Ag | Method for the treatment of biological tissue of animal or human origin, such as porcine, bovine pericardium or human cadaver heart valves, and biological tissue treated accordingly |
US9095430B2 (en) | 2010-08-24 | 2015-08-04 | Southern Lights Ventures (2002) Limited | Biomaterials with enhanced properties and devices made therefrom |
-
2020
- 2020-01-15 IT IT102020000000616A patent/IT202000000616A1/it unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030125813A1 (en) | 2002-01-03 | 2003-07-03 | Carpentier Sophie M. | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
US20060217804A1 (en) * | 2005-03-25 | 2006-09-28 | Dove Jeffrey S | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
EP1861132A2 (en) | 2005-03-25 | 2007-12-05 | Edwards Lifesciences Corporation | Treatment of bioprosthetic tissues to mitigate post implantation calcification |
US8426199B2 (en) | 2007-02-24 | 2013-04-23 | Gfe Nanomedical International Ag | Method for the treatment of biological tissue of animal or human origin, such as porcine, bovine pericardium or human cadaver heart valves, and biological tissue treated accordingly |
US9095430B2 (en) | 2010-08-24 | 2015-08-04 | Southern Lights Ventures (2002) Limited | Biomaterials with enhanced properties and devices made therefrom |
Non-Patent Citations (13)
Title |
---|
CARPENTIER A, J. THORAC. CARDIOVASCULAR SURGER, vol. 58, 1969, pages 467 - 83 |
CARPENTIER A.: "biological tissues in heart Valve Replacement", 1972, BUTTERWORTH |
GOLOMB G., AM. J PATHOL, vol. 127, 1987, pages 122 - 130 |
LEE CH ET AL., J. BIOMED. MATER. JOURNAL OF CLINICAL AND CLINICAL RESEARCH, vol. 42, no. 1, 1998, pages 30 - 7 |
LEE W ET AL., BIOMATERIALS, vol. 21, no. 22, 2000, pages 2323 - 30 |
LONESCU MI ET AL., ANN THORAC SURG, vol. 34, 1982, pages 265 - 277 |
MAGLIGAN DJ ET AL., J THORAC CARDIOVASCULAR SURG, vol. 90, 1985, pages 872 - 881 |
MILAN A ET AL., AM J CARDIOL, vol. 53, 1984, pages 1066 - 1070 |
MUNNELLY A ET AL., BIOMATERIALS, vol. 33, no. 1, 2012, pages 1 - 8 |
PARK CS ET AL.: "interact Cardiovascular", THORAC SURG, vol. 25, no. 3, 1 September 2017 (2017-09-01), pages 391 - 399 |
REUL GJ ET AL., J VASC SURG, vol. 2, 1985, pages 192 - 204 |
SANDERS SP ET AL., AM J CARDIOL, vol. 46, 1980, pages 429 - 438 |
SCHOENET FJ ET AL., CARDIOL CLIN, vol. 2, 1984, pages 717 - 739 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2019000287A (es) | Anticuerpos monoclonales contra el inhibidor de la vía del factor tisular (tfpi) | |
Wang et al. | Fluvastatin inhibits the expression of tumor necrosis factor-+ A7E and activation of nuclear factor-+ A7o-B in human endothelial cells stimulated by C-reactive protein | |
Gómez-Guzmán et al. | Chronic (−)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats | |
ES2429518T3 (es) | Preparación farmacéutica que comprende sobrenadante de cultivo de células mononucleares sanguíneas | |
DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
Lu et al. | Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-α and iNOS | |
EA201171306A1 (ru) | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ИМИДАЗО[1,2-α]ПИРИДИНА, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И СПОСОБЫ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКРЕТАЗЫ | |
CL2017003218A1 (es) | Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi) | |
ATE517085T1 (de) | Zur behandlung von atemwegserkrankungen geeignete phenoxyessigsäurederivate | |
DE602005026866D1 (de) | Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen | |
CO6531414A2 (es) | Aptámeros del inhibidor de la vía del factor tisular y sus usos como tratamiento de trastornos hemorrágicos | |
ATE516037T1 (de) | Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen | |
EP4364745A3 (en) | Novel lactic acid bacteria and use thereof | |
UA114304C2 (uk) | Спосіб зниження сироваткових рівнів сечової кислоти у людини | |
Gutiérrez-Venegas et al. | Apigenin reduce lipoteichoic acid-induced inflammatory response in rat cardiomyoblast cells | |
EA200801107A1 (ru) | Пиразолы, пригодные для лечения воспалений | |
ATE510536T1 (de) | Verwendung von 2,5-dihydroxybenzol-derivaten zur behandlung von reaktiven gewebeerkrankungen | |
GB0025670D0 (en) | Preparation for the relief of inflammatory disease | |
Hsu et al. | Eicosapentaenoic acid attenuated oxidative stress-induced cardiomyoblast apoptosis by activating adaptive autophagy | |
FR2934052B1 (fr) | Dosage de l'activite du facteur tissulaire circulant | |
Meng et al. | Emodin inhibits tumor necrosis factor-α-induced migration and inflammatory responses in rat aortic smooth muscle cells | |
Tatipamula et al. | Anti-inflammatory properties of Dirinaria consimilis extracts in albino rats | |
ATE444069T1 (de) | Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen | |
ATE556134T1 (de) | Mesenchymstammzellen und verwendungendafür | |
IT202000000616A1 (it) | Impiego di glutaraldeide deprivata di acidi per la preparazione di tessuti biologici per bio-protesi e prevenzione della loro calcificazione |